Accepted at 4:51 p.m. Jan, 27, 2024 by Ahmed7
Author: ma7moudgamal66
Co-authors: Ahmed7
Related Note: 1473995765528
Rationale for change

The question asked what would be indicative of poor prognisis and the asnwer to this question requires this remark
Source: UWorld - Step 1 1423

Extra Extra
Text
The effects of liver failure on coagulation are followed using {{c1::PT::PT or PTT}}
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid

Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
OME

Additional Resources
Empty field
One by one
Empty field
!AK_UpdateTags::Step1decks::Zanki-Step-Decks::Zanki-Hematology-&-Oncology::Pathoma-Hematology #AK_Step1_v12::#B&B::11_Hematology::01_Hemostasis::04_Coagulopathies #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::02_Coagulopathy::Extra #AK_Step1_v12::#Bootcamp::Gastroenterology::06_Hepatic_Pathology::01_Liver_Disease_Overview #AK_Step1_v12::#SketchyPath::06_Hepatobiliary::02_Liver_Disease::01_Cirrhosis_-_Pathogenesis_&_Clinical_Manifestations #AK_Step1_v12::#UWorld::Step::1423 #AK_Step1_v12::#B&B::09_GI::03_Clinical_Gastroenterology::02_Liver_Disease #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#UWorld::Step::1291 #PANCE::EOR::Family_med #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::01_Coagulation_Cascade #AK_Step1_v12::^Systems::HemeOnc::Hematology #AK_Step1_v12::#Pathoma::04_Hemostasis::02_Secondary_Hemostasis_&_Related_Disorders #PANCE::GI::hepatic_disorders #AK_Step1_v12::#UWorld::COMLEX::24534 #AK_Step1_v12::#Bootcamp::Microbiology::28_Positive-sense_RNA_Viruses::13_Hepatitis_C_Part_1_(Pathogenesis_and_Disease) #AK_Step1_v12::#UWorld::COMLEX::24402 #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_Hematology #AK_Step1_v12::#UWorld::Step::369 #AK_Step1_v12::#Physeo::11_Pathology::10_HemeOnc_Pathology::02_Secondary_Hemostasis #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Step2_v12::#B&B::06_GI::02_Liver::01_Liver_Disease #AK_Step1_v12::#UWorld::#UWSA3 #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::02_Bleeding_Time,_Prothrombin_Time,_INR,_and_Partial_Thromboplastin_Time #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::16_Coagulation_disorders::*Liver_Failure #AK_Step1_v12::#UWorld::COMLEX::23482 #AK_Step2_v12::#SketchyIM::11_Hepatobiliary::01_General_Approach::01_Abnormal_Liver_Labs_DDx #AK_Step2_v12::#B&B::06_GI::02_Liver::03_Cirrhosis #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::09_Vitamin_K_Dependent_Coagulation_Factors